Every time Americans purchase prescription drugs, they end up paying higher prices so that foreign governments can pay less. Countries such as Germany and Canada use price controls and trade tactics to force pharmaceutical companies to sell the same medications at significantly lower prices than those charged in the United States.

We shoulder the costs of innovation that lead to these medicines. The investments in research and development are largely funded by U.S. patients, workers, and taxpayers. While critics claim that foreign price controls increase access overseas, they achieve this by unfairly shifting the burden onto Americans.